Brainstorm Cell Therapeutics Inc. (BCLI) Reaches $4.35 After 6.00% Up Move; Natixis Asset Management Trimmed Its Texas Instruments (TXN) Holding

May 18, 2018 - By reb123z

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Logo

The stock of Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) is a huge mover today! The stock increased 7.17% or $0.29 during the last trading session, reaching $4.35. About 179,733 shares traded or 157.58% up from the average. Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) has declined 23.19% since May 18, 2017 and is downtrending. It has underperformed by 34.74% the S&P500.The move comes after 8 months positive chart setup for the $82.97 million company. It was reported on May, 18 by Barchart.com. We have $4.61 PT which if reached, will make NASDAQ:BCLI worth $4.98M more.

Natixis Asset Management decreased Texas Instruments (TXN) stake by 11.7% reported in 2017Q4 SEC filing. Natixis Asset Management sold 29,152 shares as Texas Instruments (TXN)’s stock declined 1.51%. The Natixis Asset Management holds 220,100 shares with $22.99M value, down from 249,252 last quarter. Texas Instruments now has $108.98 billion valuation. The stock increased 0.62% or $0.68 during the last trading session, reaching $111.01. About 1.29 million shares traded. Texas Instruments Incorporated (NASDAQ:TXN) has risen 27.36% since May 18, 2017 and is uptrending. It has outperformed by 15.81% the S&P500.

Since January 25, 2018, it had 0 insider buys, and 24 selling transactions for $122.64 million activity. Another trade for 18,571 shares valued at $2.02M was sold by ANDERSON STEPHEN A.. Another trade for 15,877 shares valued at $1.73 million was sold by XIE BING. $5.15 million worth of Texas Instruments Incorporated (NASDAQ:TXN) was sold by RITCHIE KEVIN J on Thursday, February 15. Ilan Haviv sold $7.03M worth of Texas Instruments Incorporated (NASDAQ:TXN) on Thursday, May 10. PATSLEY PAMELA H sold $776,720 worth of stock. Whitaker Darla H had sold 18,145 shares worth $1.98 million. The insider TROCHU CYNTHIA HOFF sold 3,574 shares worth $395,472.

Analysts await Texas Instruments Incorporated (NASDAQ:TXN) to report earnings on July, 24. They expect $1.30 earnings per share, up 26.21% or $0.27 from last year’s $1.03 per share. TXN’s profit will be $1.28B for 21.35 P/E if the $1.30 EPS becomes a reality. After $1.21 actual earnings per share reported by Texas Instruments Incorporated for the previous quarter, Wall Street now forecasts 7.44% EPS growth.

Natixis Asset Management increased Dish Network Corp stake by 1,100 shares to 2,471 valued at $2.73M in 2017Q4. It also upped Hexcel Corp. (NYSE:HXL) stake by 10,744 shares and now owns 179,330 shares. Edgewell Personal Care Co was raised too.

Investors sentiment decreased to 1.01 in 2017 Q4. Its down 0.11, from 1.12 in 2017Q3. It dived, as 47 investors sold TXN shares while 383 reduced holdings. 123 funds opened positions while 312 raised stakes. 805.57 million shares or 0.35% more from 802.74 million shares in 2017Q3 were reported. Winslow Evans And Crocker holds 0.03% of its portfolio in Texas Instruments Incorporated (NASDAQ:TXN) for 992 shares. Sather Incorporated has invested 0.2% in Texas Instruments Incorporated (NASDAQ:TXN). Jnba Fincl Advsr has 0.06% invested in Texas Instruments Incorporated (NASDAQ:TXN) for 2,507 shares. Sei Invests holds 0.24% of its portfolio in Texas Instruments Incorporated (NASDAQ:TXN) for 669,327 shares. State Of Wisconsin Inv Board reported 1.32 million shares. University Of Texas Investment Managment has 32,000 shares for 12.9% of their portfolio. Glob X Mngmt Company Limited Company has 10,802 shares. Webster Bancorp N A invested in 3,659 shares. Greenwich Wealth Mgmt Ltd Llc holds 0.04% or 2,114 shares in its portfolio. Patten & Patten Tn accumulated 115,544 shares or 1.21% of the stock. 18,749 were reported by Caprock Grp Inc Inc. Covington Capital Mgmt has 0.04% invested in Texas Instruments Incorporated (NASDAQ:TXN). Moreover, State Of Alaska Department Of Revenue has 0.51% invested in Texas Instruments Incorporated (NASDAQ:TXN) for 203,552 shares. Virtu Ltd Liability Com has 0.07% invested in Texas Instruments Incorporated (NASDAQ:TXN) for 11,858 shares. Capital Investors holds 1.69% of its portfolio in Texas Instruments Incorporated (NASDAQ:TXN) for 14.37 million shares.

Another recent and important Texas Instruments Incorporated (NASDAQ:TXN) news was published by Investorplace.com which published an article titled: “Texas Instruments Incorporated (TXN) Shares Soar on Q1 Earnings Beat” on April 24, 2018.

Among 42 analysts covering Texas Instruments (NASDAQ:TXN), 19 have Buy rating, 3 Sell and 20 Hold. Therefore 45% are positive. Texas Instruments had 119 analyst reports since July 24, 2015 according to SRatingsIntel. As per Tuesday, December 15, the company rating was upgraded by Oppenheimer. On Monday, January 9 the stock rating was upgraded by Credit Suisse to “Outperform”. Bernstein maintained Texas Instruments Incorporated (NASDAQ:TXN) on Wednesday, January 24 with “Buy” rating. The firm has “Buy” rating given on Friday, September 22 by Jefferies. The rating was maintained by M Partners on Thursday, January 28 with “Neutral”. The stock of Texas Instruments Incorporated (NASDAQ:TXN) has “Buy” rating given on Thursday, July 20 by Oppenheimer. The company was maintained on Tuesday, November 21 by KeyBanc Capital Markets. The company was maintained on Wednesday, April 25 by FBR Capital. The stock of Texas Instruments Incorporated (NASDAQ:TXN) has “Sell” rating given on Wednesday, February 3 by Goldman Sachs. The rating was downgraded by B. Riley & Co on Thursday, October 22 to “Neutral”.

More recent Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) news were published by: Benzinga.com which released: “22 Stocks Moving In Thursday’s Pre-Market Session” on May 17, 2018. Also Seekingalpha.com published the news titled: “Key events next week – healthcare” on May 11, 2018. Benzinga.com‘s news article titled: “Earnings Scheduled For May 14, 2018” with publication date: May 14, 2018 was also an interesting one.

Among 2 analysts covering Brainstorm Cell Therapeutics (NASDAQ:BCLI), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Brainstorm Cell Therapeutics had 6 analyst reports since August 12, 2015 according to SRatingsIntel. The stock has “Buy” rating by H.C. Wainwright on Tuesday, May 15. The firm earned “Buy” rating on Wednesday, August 12 by Maxim Group. Maxim Group maintained it with “Buy” rating and $800 target in Tuesday, June 13 report. Maxim Group maintained Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) rating on Friday, July 21. Maxim Group has “Buy” rating and $800 target. As per Tuesday, December 22, the company rating was maintained by Maxim Group. Maxim Group maintained Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) rating on Wednesday, August 16. Maxim Group has “Buy” rating and $9.0 target.

Texas Instruments Incorporated (NASDAQ:TXN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>